Science Explorer Interactive view Map
Company · Bengaluru · India

Novo Nordisk (India)

novonordisk.co.inROR OpenAlex
Research works
76
▲ 48% vs 2013–17
Citations
868
11.5 per fractional work
Top-10% rate
16.2%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: Novo Nordisk (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

What does Novo Nordisk (India) specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.7× the share of its output that it takes of world research.

  1. MedicineField · 20.8 works3.7×
  2. Health SciencesDomain · 22.0 works3.2×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.36× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.89× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.79× its world share, 0 worksImmunology and Micro…Neuroscience: 1.21× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.60× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.29× its world share, 1 worksComputer ScienceEngineering: 0.23× its world share, 1 worksEngineeringEnvironmental Science: 0.43× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.69× its world share, 1 worksMaterials ScienceMathematics: 0.96× its world share, 0 worksMathematicsHealth Professions: 0.37× its world share, 0 worksHealth ProfessionsMedicine: 3.67× its world share, 21 worksMedicineNursing: 1.46× its world share, 0 worksNursingVeterinary: 16.64× its world share, 1 worksVeterinaryBusiness, Management and Accounting: 0.16× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.67× its world share, 1 worksEconomics, Econometr…Psychology: 0.09× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 16.6×. Every wedge is a field page.

Which keywords describe research at Novo Nordisk (India)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Diabetes, Cardiovascular Disease, Type 2 Diabetes, Metabolic Syndrome, Clinical Guidelines and Heart Failure.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 34 words, with their numbers
  1. Glycemic Control7▲ 151×4 topics
  2. Insulin Therapy7▲ 186×3 topics
  3. Diabetes6▲ 39×7 topics
  4. Cardiovascular Disease4▲ 14×8 topics
  5. Type 2 Diabetes4▲ 64×3 topics
  6. Clinical Guidelines4▲ 42×4 topics
  7. Metabolic Syndrome4▲ 15×8 topics
  8. Heart Failure3▲ 26×3 topics
  9. Obesity3▲ 15×10 topics
  10. Cardiovascular Outcomes3▲ 199×1 topic
  11. Glucose Control3▲ 199×1 topic
  12. Type 1 Diabetes3▲ 109×2 topics
  13. Complications3▲ 18×2 topics
  14. Insulin Resistance3▲ 20×4 topics
  15. Continuous Glucose Monitoring2▲ 183×1 topic
  16. Hypoglycemia2▲ 183×1 topic
  17. Epidemiology2▲ 1.94×16 topics
  18. Lifestyle Intervention2▲ 90×2 topics
  19. Atherosclerosis2▲ 23×3 topics
  20. Cardiovascular Risk2▲ 16×5 topics
  21. Glucose Metabolism2▲ 53×2 topics
  22. Cholesterol1▲ 34×1 topic
  23. Global Prevalence1▲ 54×1 topic
  24. Weight Loss1▲ 29×4 topics
  25. Diabetes Mellitus1▲ 22×3 topics
  26. Hyperglycemia1▲ 36×2 topics
  27. Clinical Trials1▲ 5.8×6 topics
  28. Critical Care1▲ 17×3 topics
  29. Hepatic Steatosis1▲ 25×2 topics
  30. Inflammation1▲ 1.83×10 topics
  31. Mortality1▲ 6.2×2 topics
  32. NAFLD1▲ 30×1 topic
  33. NASH1▲ 30×1 topic
  34. Intensive Care Unit1▲ 29×2 topics

Which research topics does Novo Nordisk (India) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins and Liver Disease Diagnosis and Treatment.

Diabetes Treatment and M…3Diabetes Treatment and Management: 3 fractional worksDiabetes Management and Research: 2 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 1 fractional worksLiver Disease Diagnosis and Treatment: 1 fractional worksHyperglycemia and glycemic control in critically ill and hospitalized patients: 1 fractional worksBariatric Surgery and Ou…1Bariatric Surgery and Outcomes: 1 fractional worksPharmaceutical Economics and Policy: 1 fractional worksMetabolism, Diabetes, and Cancer: 1 fractional worksHemophilia Treatment and Research: 0 fractional worksGrowth Hormone and Insulin-like Growth Factors: 0 fractional works
Endocrinology, Diabetes and MetabolismEpidemiologySurgeryEconomics and Econometrics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 3 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 2 works
  3. 3 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
  4. 4 Liver Disease Diagnosis and Treatment Epidemiology 1 works
  5. 5 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 1 works
  6. 6 Bariatric Surgery and Outcomes Surgery 1 works
  7. 7 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  8. 8 Metabolism, Diabetes, and Cancer Molecular Biology 1 works
  9. 9 Hemophilia Treatment and Research Hematology 0 works
  10. 10 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.3%not open46.7%

World: 28% of research is openly available.

with international co-authors60.4%domestic only39.6%

World: 19% is written across borders.

How has Novo Nordisk (India)'s research output changed?

Output in 2018–2022 was 48% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Bengaluru

All research institutions in Bengaluru

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.